Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P1.01-065 - Treatment Beyond Progression with Nivolumab in Patients with Advanced Non-Squamous NSCLC: Results from the Italian Expanded Access Program
09:30 - 09:30 | Presenter: Enrico Cortesi | Author(s): Francesco Grossi, R. Chiari, G. Azzarello, R. Berardi, D. Tassinari, G. Palmiotti, C. Verusio, A. Ardizzoia, L. Fioretto, L. Livi, S. Giusti, A. Bearz, G.L. Ceresoli, F. Piantedosi, A. Frassoldati, E. Ricevuto, G. Fasola, P. Marchetti, G. Puppo
- Abstract
Loading...
-
+
MA 01 - SCLC: Research Perspectives
- 11:00 - 12:30
- 10/16/2017
- Location: Room 503
- Type: Mini Oral
- Track: SCLC/Neuroendocrine Tumors
- Moderators:John V Heymach, Eun Kyung Cho
-
+
MA 01.07 - Lanreotide Maintenance in SCLC Expressing Somatostatine Receptors: Efficacy Results of Multicenter Randomized G04.2011 Trial
11:40 - 11:45 | Presenter: Sara Pilotto | Author(s): E. Bria, Domenico Galetta, Francesco Grossi, G. Fasola, G. Romano, L. Bonanno, A. Bearz, M. Papi, A. Caprioli, A. Catino, A. Follador, E. Rijavec, A. Misino, G. Surico, A. Favaretto, L. Giannone, G. Tortora, D. Giannarelli, A. Santo
- Abstract
Loading...
-
+
OA 02 - Mesothelioma: Challenges For New Treatment
- 11:00 - 12:30
- 10/16/2017
- Location: F205 + F206 (Annex Hall)
- Type: Oral
- Track: Mesothelioma
- Moderators:S. Hasegawa, Anna Nowak
-
+
OA 02.01 - Randomized Phase II Study of Anetumab Ravtansine or Vinorelbine in Patients with Malignant Pleural Mesothelioma
11:00 - 11:10 | Presenter: Hedy Lee Kindler | Author(s): Silvia Novello, Dean A Fennell, G. Blumenschein, A. Bearz, G.L. Ceresoli, J.G. Aerts, J. Spicer, P. Taylor, A. Greystoke, K. Nackaerts, Luana Calabro, S. Burgers, R. Jennens, A.F. Sporchia, A. Walter, J. Siegel, B.H. Childs, C. Elbi, R. Hassan
- Abstract
Loading...
-
+
OA 05 - Next Generation TKI
- 15:45 - 17:30
- 10/16/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Advanced NSCLC
- Moderators:James Chih-Hsin Yang, Fiona Blackhall
-
+
OA 05.06 - Phase 2 Study of Lorlatinib in Patients with Advanced ALK+/ROS1+ Non-Small-Cell Lung Cancer
16:40 - 16:50 | Presenter: Ben J Solomon | Author(s): Alice Shaw, Sai-Hong Ignatius Ou, Benjamin Besse, Enriqueta Felip, T.M. Bauer, R.A. Soo, A. Bearz, Chia-Chi Lin, J.S. Clancy, A. Abbattista, H. Thurm, G. Peltz, E.T. Masters, J. Martini, L.P. James, Takashi Seto
- Abstract
Loading... -
+
OA 05.07 - Efficacy and Updated Safety of Ceritinib (450 Mg or 600 Mg) with Low-Fat Meal vs 750 Mg Fasted in ALK+ Metastatic NSCLC
16:50 - 17:00 | Presenter: Byoung Chul Cho | Author(s): R. Obermannová, A. Bearz, D. Kim, S. Orlov, G. Borra, Sang-We Kim, Pieter E. Postmus, S.A. Laurie, Keunchil Park, S.L. Geater, A.C. Bettini, K. Osborne, V.Q. Passos, Z. Chen, Rafal Dziadziuszko
- Abstract
Loading...